Contribution of sodium channel neuronal isoform Nav1.1 to late sodium current in ventricular myocytes from failing hearts

S Mishra, V Reznikov, VA Maltsev… - The Journal of …, 2015 - Wiley Online Library
S Mishra, V Reznikov, VA Maltsev, NA Undrovinas, HN Sabbah, A Undrovinas
The Journal of physiology, 2015Wiley Online Library
Key points Late Na+ current (INaL) contributes to action potential remodelling and
Ca2+/Na+ changes in heart failure. The molecular identity of INaL remains unclear. The
contributions of different Na+ channel isoforms, apart from the cardiac isoform, remain
unknown. We discovered and characterized a substantial contribution of neuronal isoform
Nav1. 1 to INaL. This new component is physiologically relevant to the control of action
potential shape and duration, as well as to cell Ca2+ dynamics, especially in heart failure …
Key points
  • Late Na+ current (INaL) contributes to action potential remodelling and Ca2+/Na+ changes in heart failure.
  • The molecular identity of INaL remains unclear.
  • The contributions of different Na+ channel isoforms, apart from the cardiac isoform, remain unknown.
  • We discovered and characterized a substantial contribution of neuronal isoform Nav1.1 to INaL.
  • This new component is physiologically relevant to the control of action potential shape and duration, as well as to cell Ca2+ dynamics, especially in heart failure.
Abstract
Late Na+ current (INaL) contributes to action potential (AP) duration and Ca2+ handling in cardiac cells. Augmented INaL was implicated in delayed repolarization and impaired Ca2+ handling in heart failure (HF). We tested if Na+ channel (Nav) neuronal isoforms contribute to INaL and Ca2+ cycling defects in HF in 17 dogs in which HF was achieved via sequential coronary artery embolizations. Six normal dogs served as control. Transient Na+ current (INaT) and INaL in left ventricular cardiomyocytes (VCMs) were recorded by patch clamp while Ca2+ dynamics was monitored using Fluo‐4. Virally delivered short interfering RNA (siRNA) ensured Nav1.1 and Nav1.5 post‐transcriptional silencing. The expression of six Navs was observed in failing VCMs as follows: Nav1.5 (57.3%) > Nav1.2 (15.3%) > Nav1.1 (11.6%) > Nav2.1 (10.7%) > Nav1.3 (4.6%) > Nav1.6 (0.5%). Failing VCMs showed up‐regulation of Nav1.1 expression, but reduction of Nav1.6 mRNA. A similar Nav expression pattern was found in samples from human hearts with ischaemic HF. VCMs with silenced Nav1.5 exhibited residual INaT and INaL (∼30% of control) with rightwardly shifted steady‐state activation and inactivation. These currents were tetrodotoxin sensitive but resistant to MTSEA, a specific Nav1.5 blocker. The amplitude of the tetrodotoxin‐sensitive INaL was 0.1709 ± 0.0299 pA pF–1 (n = 7 cells) and the decay time constant was τ = 790 ± 76 ms (n = 5). This INaL component was lacking in VCMs with a silenced Nav1.1 gene, indicating that, among neuronal isoforms, Nav1.1 provides the largest contribution to INaL. At –10 mV this contribution is ∼60% of total INaL. Our further experimental and in silico examinations showed that this new Nav1.1 INaL component contributes to Ca2+ accumulation in failing VCMs and modulates AP shape and duration. In conclusion, we have discovered an Nav1.1‐originated INaL component in dog heart ventricular cells. This component is physiologically relevant to controlling AP shape and duration, as well as to cell Ca2+ dynamics.
Wiley Online Library